Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LAGS SPINE AND SPORTSCARE MEDICAL CENTERS, INC.

NPI: 1255828174 · VENTURA, CA 93003 · Pain Medicine (Physical Medicine & Rehabilitation) Physician · NPI assigned 04/16/2018

$617K
Total Medicaid Paid
11,565
Total Claims
11,254
Beneficiaries
33
Codes Billed
2018-06
First Month
2021-05
Last Month

Provider Details

Authorized OfficialD'AMATO, AMY (CONTRACTS MANAGER)
NPI Enumeration Date04/16/2018

Related Entities

Other providers sharing the same authorized official: D'AMATO, AMY

ProviderCityStateTotal Paid
LAGS SPINE AND SPORTSCARE MEDICAL CENTERS, INC. SALINAS CA $374K
LAGS SPINE AND SPORTSCARE MEDICAL CENTERS, INC. MERCED CA $353K
LAGS SPINE AND SPORTSCARE MEDICAL CENTERS, INC. PORTLAND OR $4K
LAGS SPINE AND SPORTSCARE MEDICAL CENTERS, INC. SACRAMENTO CA $640.91

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,290 $7K
2019 5,920 $375K
2020 4,147 $223K
2021 208 $13K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4,627 4,454 $277K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 513 507 $106K
99490 Ccm add 20min 1,209 1,209 $53K
95886 232 219 $37K
96138 955 942 $31K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 575 559 $23K
95911 95 91 $17K
88356 14 14 $9K
99442 244 244 $8K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 97 95 $7K
88360 14 14 $6K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 54 54 $5K
64483 32 24 $5K
99443 102 99 $5K
99000 2,045 1,992 $4K
64635 15 14 $4K
88319 14 14 $3K
95924 19 19 $3K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 33 33 $3K
88314 14 14 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination 14 14 $2K
95913 13 12 $2K
64636 15 14 $2K
99406 147 145 $2K
Q3014 Telehealth originating site facility fee 81 77 $1K
S0020 Injection, bupivicaine hydrochloride, 30 ml 67 65 $790.87
96103 103 103 $569.80
J1100 Injection, dexamethasone sodium phosphate, 1 mg 76 75 $456.28
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 15 15 $264.29
T1014 Telehealth transmission, per minute, professional services bill separately 66 62 $100.44
97813 17 16 $69.50
97814 17 16 $69.50
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 31 29 $0.00